
Currently out of the existing stock ratings of Martin Auster, 145 are a BUY (73.6%), 11 are a SELL (5.58%), 41 are a HOLD (20.81%).
Analyst Martin Auster, currently employed at RAYMOND JAMES, has had 72.04% of price targets met with an average potential upside of 33.62%, reached in 276 days on average.
Martin Auster has documented 392 price targets and ratings displayed on 44 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 30-Oct-2026.
Analyst best performing recommendations are on FTSV (FORTY SEVEN).
The best stock recommendation documented was for ALNY (ALNYLAM PHARMACEUTICALS) on 7/29/2025. The price target of $370 was fulfilled within 2 days with a profit of $39.45 (11.93%), with a performance score of 59.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2017
$205
5 years 6 months 16 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 03-May-2021
$173
$156
5 years 6 months 18 days ago
(03-May-2021)
18/29 (62.07%)
$2.73 (1.60%)
667
Buy Since 08-Feb-2018
$166
$179
5 years 9 months 17 days ago
(04-Feb-2021)
21/21 (100%)
$10.41 (6.69%)
711
Hold Since 04-Feb-2021
$190
$194
5 years 9 months 17 days ago
(04-Feb-2021)
13/15 (86.67%)
$34.41 (22.12%)
458
Buy Since 06-Sep-2019
$175
$165
5 years 9 months 17 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Stocks Martin Auster covered previously. Scores are shown for active stocks only.
The record of these past calls is part of the data set at anachart.store.
Which stock is Martin Auster most bullish on?
Which stock is Martin Auster most reserved on?
What Year was the first public recommendation made by Martin Auster?